cancer research

A wayward lab chair ended three days of work in a single footfall for Elinne Becket.

Oncolytic virotherapy selectively attacks tumors and triggers both immediate and long-lasting immune responses. 

Discover the benefits of VHH antibody-based therapies.

An on-off enzyme switch controls metastasis in mice. 

Vaginal dysbiosis has long been a taboo subject, but studying and optimizing the vaginal microbiome could be a game changer for women's health.

Researchers investigated how cancer antigenicity drives unique forms of T cell exhaustion and hypofunctionality.

A genetic study tracked the evolution of two transmissible cancers currently ravaging populations of Tasmanian devils.

From early target discovery to preclinical development stages, researchers explore novel strategies for effective cell therapies in cancer treatment.

Colonizing tumors with engineered bacteria may allow researchers to target sites currently inaccessible to radionuclide therapy.

Viscous solutions accelerate the migration of tumor cells and may enable metastasis, according to a new study.

Islands of rigid cells within a matrix of soft ones allow tumors to be both solid and fluid, granting them toughness without losing the ability to break apart.

The donation will fund recruitment, research facilities, clinical research, and immunotherapy research.

From histopathology to multiplex immunohistochemistry and spatial transcriptomics, learn how to obtain the appropriate profiling depth to match cancer classification needs.

A study finds that engineered exosomes are effective in mice, but their potential use in humans raises safety questions.  

As the new agency’s director, the DARPA veteran will spearhead a high-risk, high-reward approach to biomedical research.

An in situ map of copy number variations in prostate tissue reveals that purportedly cancerous genomic changes frequently occur in the healthy tissue surrounding tumors.

The announcement confirms earlier reports that Bertagnolli will become the first woman to lead the National Cancer Institute since its founding in 1937.

Neuron-like glioblastoma cells are the pioneers of deadly tumors’ spread through the brain, contributing to their devastating invasiveness, a study in mice finds.

A previously overlooked enzyme called APOBEC3A is linked to the most prevalent mutational signatures in cancer cell lines, a study finds.